Teprenone
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H38O |
| Molar mass | 330.556 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Teprenone (or geranylgeranylacetone) is a pharmaceutical drug used for the treatment of gastric ulcers.[1]
In Japan it is sold under the brand name Selbex (セルベックス).
References
- ↑ Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879. S2CID 19387865.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.